Pediatric Asthma Treatment Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Pediatric Asthma Treatment Market covers analysis By Product type (Dry powder inhalers, Metered dose inhalers, Mist inhalers, Nebulizer); Drug class (Anti-inflammatory drugs, Bronchodilators, Combination therapy); Route of administration (Oral, Inhaled, Intravenous, Subcutaneous) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00015283
  • Category : Pharmaceuticals
  • No. of Pages : 150

Pediatric Asthma Treatment Market Dynamics 2021-2031

Buy Now

MARKET INTRODUCTION

Asthma is a chronic disease which shows various symptoms such as coughing, wheezing, chest tightness and breath shortness. Environmental and genetic factors are major cause of the asthma. The environmental factors include exposure to air pollution, pollen grains and allergens. The pulmonary airway muscles get swollen due to allergens, which cause bronchospasm and airway obstruction. Patients with genetic history of asthma are more prone to developing asthma. Asthma can be controlled by early asthma treatment. The medications include long acting beta-agonists (LABA), corticosteroids, anti-inflammatory agents and leukotriene modifiers. Asthma patients are always at risk of developing with pneumonia and influenza. Diagnosis and treatment of asthma in pediatric has remained a challenge.

MARKET DYNAMICS

The pediatric asthma treatment market is growing due to the rise in asthma incidences and growing allergy cases. However, the high cost of pediatric asthma treatment is expected to hamper the growth of the global pediatric asthma treatment market.

MARKET SCOPE

The "Pediatric Asthma Treatment Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Pediatric Asthma Treatment market with detailed market segmentation product type, drug class, route of administration and geography. The Pediatric Asthma Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Pediatric Asthma Treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Pediatric Asthma Treatment market is segmented on the basis of product type, drug class and route of administration. Based on products type, the market is segmented as dry powder inhalers, metered dose inhalers, mist inhalers and nebulizer. On the basis of drug class, the global asthma therapeutics market is segmented into anti-inflammatory drugs, bronchodilators and combination therapy. Based on route of administration, the market segmented into oral, inhaled, intravenous and subcutaneous.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Pediatric Asthma Treatment market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pediatric Asthma Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Pediatric Asthma Treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pediatric Asthma Treatment market in these regions.

Pediatric Asthma Treatment Market Report Analysis

Pediatric Asthma Treatment Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Teva Pharmaceutical Industries Ltd
  • Merck KGaA
  • GlaxoSmithKline Plc
  • F Hoffmann La Roche Ltd
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Sanofi SA
  • Sunovion Pharmaceuticals Inc
  • CareFusion Corporation

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market Segment By Product type
  • Dry powder inhalers
  • Metered dose inhalers
  • Mist inhalers
  • Nebulizer
Market Segment By Drug class
  • Anti-inflammatory drugs
  • Bronchodilators
  • Combination therapy
Market Segment By Route of administration
  • Oral
  • Inhaled
  • Intravenous
  • Subcutaneous
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The report covers key developments in the Pediatric Asthma Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pediatric Asthma Treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pediatric Asthma Treatment in the global market. Below mentioned is the list of few companies engaged in the Pediatric Asthma Treatment market.

The report also includes the profiles of key players in Pediatric Asthma Treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Teva Pharmaceutical Industries Ltd.
  •  Merck KGaA
  •  GlaxoSmithKline Plc
  •  F. Hoffmann La-Roche Ltd.
  •  AstraZeneca Plc
  •  Boehringer Ingelheim GmbH
  •  Sanofi SA
  •  Sunovion Pharmaceuticals, Inc.
  •  CareFusion Corporation
  •  Philips Healthcare

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Pediatric Asthma Treatment Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product type
  • Dry powder inhalers
  • Metered dose inhalers
  • Mist inhalers
  • Nebulizer
By Drug class
  • Anti-inflammatory drugs
  • Bronchodilators
  • Combination therapy
By Route of administration
  • Oral
  • Inhaled
  • Intravenous
  • Subcutaneous
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Teva Pharmaceutical Industries Ltd
  • Merck KGaA
  • GlaxoSmithKline Plc
  • F Hoffmann La Roche Ltd
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Sanofi SA
  • Sunovion Pharmaceuticals Inc
  • CareFusion Corporation
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Segment Covered

This text is related
to segments covered.

Regional Scope

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Country Scope

This text is related
to country scope.

The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. Merck KGaA
3. GlaxoSmithKline Plc
4. F. Hoffmann La-Roche Ltd.
5. AstraZeneca Plc
6. Boehringer Ingelheim GmbH
7. Sanofi SA
8. Sunovion Pharmaceuticals, Inc.
9. CareFusion Corporation
10. Philips Healthcare

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..